|
Controversial board move doesn’t stop StemCells from raising $20 million
San Francisco Business Times (blog) In the offering, StemCells will sell nearly 11.3 million shares of common stock as well as short-term warrants for the purchase of more than 9.6 million additional shares. The stock and warrants will be sold as units of one share of stock and a warrant … StemCells, Inc. Announces Proposed $20 Million OfferingMarketWatch |
